Skip to main content
. 2021 Jun 13;42(25):2455–2467. doi: 10.1093/eurheartj/ehab312

Figure 5.

Figure 5

Distribution of estimated 10-year non-fatal and fatal cardiovascular disease events and estimated 10-year absolute risk reduction from lipid lowering in older persons with cholesterol >2.6 mmol/L in the PROSPER trial (n = 3051).